Epidemiologic classification of human papillomavirus types associated with cervical cancer

New England Journal of Medicine

Volumn 348, Issue 6, 2003, Pages 518-527

  Muñoz, Nubia ^a,d   Bosch, F Xavier ^b   De Sanjosé, Silvia ^b   Herrero, Rolando ^c   Castellsagué, Xavier ^b   Shah, Keerti V ^e   Snijders, Peter J F ^e   Meijer, Chris J L M ^e  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c Costa Rican Found for Hlth Sci ^*  (Costa Rica)

^d HOSPITAL DURAN I REYNALS   (Spain)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA FINGERPRINTING; EPIDEMIOLOGICAL DATA; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERVIEW; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS STRAIN; VIRUS TYPING; WART VIRUS;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HUMANS; ODDS RATIO; PAPILLOMAVIRIDAE; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0037421589     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021641     Document Type: Article

References (31)

1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase no. 5. Lyons, France: IARC Press, 2001.
2. Muñoz N, Bosch FX, de Sanjosé S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-9.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
4. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
5. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
6. Kjaer SK, van den Brule AJC, Bock JE, et al. Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65:601-6.
7. de Villiers E-M. Taxonomic classification of papillomaviruses. Papillmavirus Rep 2001;12:57-63.
8. Jacobs MV, de Roda Husman AM, van den Brule AJC, Snijders PJF, Meijer CJLM, Walboomers JMM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33:901-5.
9. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJLM, Snijders PJ. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40:779-87.
10. Davies P, Kornegay J, Iftner T. Current methods of testing for human papillomavirus. Best Pract Res Clin Obstet Gynaecol 2001;15:677-700.
11. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCK products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
12. Van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 1992;73:2653-60.
13. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human papillomaviruses. Lyons, France: International Agency for Research on Cancer, 1995.
14. Chaouki N, Bosch FX, Muñoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-54.
15. Bayo S, Bosch FX, de Sanjose S, et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002;31:202-9.
16. Bosch FX, Muñoz N, de Sanjosé S, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-22.
17. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-9.
18. Rolón PA, Smith JS, Muñoz N, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000;85:486-91.
19. Santos C, Muñoz N, Klug S, et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001;85:966-71.
20. Chichareon S, Herrero R, Muñoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-7.
21. Ngelangel C, Muñoz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998;90:43-9.
22. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M, eds. Cancer cells. Vol. 7. Molecular diagnostics of human cancer. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1989:209-14.
23. de Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR, J Gen Virol 1995;76:1057-62.
24. Myers G, Sverdrup F, Baker C, et al., eds. Human papillomaviruses 1997: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, N.M.: Theoretical Biology and Biophysics, Los Alamos National Laboratory, 1997.
25. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyons, France: International Agency for Research on Cancer, 1980. (IARC scientific publications no. 32.)
26. de Sanjosé S, Bosch XF, Muñoz N, et al. Screening for genital human papillomavirus: results from an international validation study on human papillomavirus sampling techniques. Diagn Mol Pathol 1999;8:26-31.
27. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
28. Durst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE, Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987;1:251-6.
29. Storey A, Pim D, Murray A, Osborn K, Banks L, Crawford L. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 1988;7:1815-20.
30. McDougall JK. Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 1994;186:101-19.
31. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-17.